Skip to main content
Erschienen in: The Cerebellum 3/2009

01.09.2009

Synchrotron X-ray Fluorescence Reveals Abnormal Metal Distributions in Brain and Spinal Cord in Spinocerebellar Ataxia: A Case Report

verfasst von: Bogdan F. Gh. Popescu, Christopher A. Robinson, L. Dean Chapman, Helen Nichol

Erschienen in: The Cerebellum | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

For the first time, synchrotron rapid-scanning X-ray fluorescence (RS-XRF) was used to simultaneously localize and quantify iron, copper, and zinc in spinal cord and brain in a case of spinocerebellar ataxia (SCA). In the normal medulla, a previously undescribed copper enrichment was seen associated with spinocerebellar fibers and amiculum olivae. This region was virtually devoid of all metals in the SCA case. Regions with neuronal loss and gliosis in the cerebellar cortex, inferior olivary, and dentate nuclei and areas showing loss of myelinated fibers were also low in all metals in SCA compared to control. In contrast, the ventral columns of the spinal cord that exhibited only moderate myelin pallor had increased metal levels. Iron and zinc were also elevated in the globus pallidus pars externa in SCA relative to control. We hypothesize that metals increase as part of the initial neurodegenerative process, but once degeneration is advanced, the metal levels drop. This implies a role for multiple metals in SCA neurodegeneration, but further study is required to establish a causative role. We suggest that if these findings are generally true of at least some cases of SCA, not only iron but also copper and zinc should be considered as possible therapeutic targets.
Fußnoten
1
A neuropathology report was provided by NICHD Brain and Tissue Bank for developmental disorders and further analysis on available tissues was performed at our institution.
 
Literatur
1.
Zurück zum Zitat Adamec J, Rusnak F, Owen WG, Naylor S, Benson LM, Gacy AM et al (2000) Iron-dependent self-assembly of recombinant yeast frataxin: implications for Friedreich ataxia. Am J Hum Genet 67(3):549–562PubMedCrossRef Adamec J, Rusnak F, Owen WG, Naylor S, Benson LM, Gacy AM et al (2000) Iron-dependent self-assembly of recombinant yeast frataxin: implications for Friedreich ataxia. Am J Hum Genet 67(3):549–562PubMedCrossRef
2.
Zurück zum Zitat Babcock M, de Silva D, Oaks R, Davis-Kaplan S, Jiralerspong S, Montermini L et al (1997) Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science 276(5319):1709–1712PubMedCrossRef Babcock M, de Silva D, Oaks R, Davis-Kaplan S, Jiralerspong S, Montermini L et al (1997) Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science 276(5319):1709–1712PubMedCrossRef
3.
Zurück zum Zitat Lamarche JB, Cote M, Lemieux B (1980) The cardiomyopathy of Friedreich's ataxia morphological observations in 3 cases. Can J Neurol Sci 7(4):389–396PubMed Lamarche JB, Cote M, Lemieux B (1980) The cardiomyopathy of Friedreich's ataxia morphological observations in 3 cases. Can J Neurol Sci 7(4):389–396PubMed
4.
Zurück zum Zitat Kaplan J (2002) Spinocerebellar ataxias due to mitochondrial defects. Neurochem Int 40(6):553–557PubMedCrossRef Kaplan J (2002) Spinocerebellar ataxias due to mitochondrial defects. Neurochem Int 40(6):553–557PubMedCrossRef
5.
Zurück zum Zitat Napier I, Ponka P, Richardson DR (2005) Iron trafficking in the mitochondrion: novel pathways revealed by disease. Blood 105(5):1867–1874PubMedCrossRef Napier I, Ponka P, Richardson DR (2005) Iron trafficking in the mitochondrion: novel pathways revealed by disease. Blood 105(5):1867–1874PubMedCrossRef
6.
Zurück zum Zitat Allikmets R, Raskind WH, Hutchinson A, Schueck ND, Dean M, Koeller DM (1999) Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A). Hum Mol Genet 8(5):743–749PubMedCrossRef Allikmets R, Raskind WH, Hutchinson A, Schueck ND, Dean M, Koeller DM (1999) Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A). Hum Mol Genet 8(5):743–749PubMedCrossRef
7.
Zurück zum Zitat Shackelford RE, Manuszak RP, Johnson CD, Hellrung DJ, Steele TA, Link CJ et al (2003) Desferrioxamine treatment increases the genomic stability of Ataxia-telangiectasia cells. DNA Repair (Amst) 2(9):971–981CrossRef Shackelford RE, Manuszak RP, Johnson CD, Hellrung DJ, Steele TA, Link CJ et al (2003) Desferrioxamine treatment increases the genomic stability of Ataxia-telangiectasia cells. DNA Repair (Amst) 2(9):971–981CrossRef
8.
Zurück zum Zitat Shackelford RE, Manuszak RP, Johnson CD, Hellrung DJ, Link CJ, Wang S (2004) Iron chelators increase the resistance of Ataxia telangeictasia cells to oxidative stress. DNA Repair (Amst) 3(10):1263–1272CrossRef Shackelford RE, Manuszak RP, Johnson CD, Hellrung DJ, Link CJ, Wang S (2004) Iron chelators increase the resistance of Ataxia telangeictasia cells to oxidative stress. DNA Repair (Amst) 3(10):1263–1272CrossRef
9.
Zurück zum Zitat Lönnqvist T, Paetau A, Pihko H, Nikali K (2000) Infantile-onset spinocerebellar ataxia. In: Klockgether T (ed) Handbook of ataxia disorders. Marcel Dekker, Inc, New York, pp 293–309 Lönnqvist T, Paetau A, Pihko H, Nikali K (2000) Infantile-onset spinocerebellar ataxia. In: Klockgether T (ed) Handbook of ataxia disorders. Marcel Dekker, Inc, New York, pp 293–309
10.
Zurück zum Zitat Bottomley SS, Muller-Eberhard U (1988) Pathophysiology of heme synthesis. Semin Hematol 25(4):282–302PubMed Bottomley SS, Muller-Eberhard U (1988) Pathophysiology of heme synthesis. Semin Hematol 25(4):282–302PubMed
11.
Zurück zum Zitat Barbeau A, Roy M, Paris S (1984) Hair trace elements in Friedreich's disease. Can J Neurol Sci 11(4 Suppl):620–622PubMed Barbeau A, Roy M, Paris S (1984) Hair trace elements in Friedreich's disease. Can J Neurol Sci 11(4 Suppl):620–622PubMed
12.
Zurück zum Zitat Huxtable RJ, Johnson P, Lippincott SE (1984) Free amino acids and calcium, magnesium and zinc levels in Friedreich's ataxia. Can J Neurol Sci 11(4 Suppl):616–619PubMed Huxtable RJ, Johnson P, Lippincott SE (1984) Free amino acids and calcium, magnesium and zinc levels in Friedreich's ataxia. Can J Neurol Sci 11(4 Suppl):616–619PubMed
13.
Zurück zum Zitat Shapcott D, Giguere R, Lemieux B (1984) Zinc and taurine in Friedreich's ataxia. Can J Neurol Sci 11(4 Suppl):623–625PubMed Shapcott D, Giguere R, Lemieux B (1984) Zinc and taurine in Friedreich's ataxia. Can J Neurol Sci 11(4 Suppl):623–625PubMed
14.
Zurück zum Zitat (2005) Snapshot: eureka moment as X-rays slice through forgery. Nature 435(7040):257 (2005) Snapshot: eureka moment as X-rays slice through forgery. Nature 435(7040):257
15.
Zurück zum Zitat Bergmann U (2007) Archimedes brought to light. Physics World 20:39–42 Bergmann U (2007) Archimedes brought to light. Physics World 20:39–42
16.
Zurück zum Zitat Service RF (2006) Imaging. Brilliant X-rays reveal fruits of a brilliant mind. Science 313(5788):744PubMedCrossRef Service RF (2006) Imaging. Brilliant X-rays reveal fruits of a brilliant mind. Science 313(5788):744PubMedCrossRef
17.
Zurück zum Zitat Gh Popescu BF, George MJ, Bergmann U, Garachtchenko AV, Kelly ME, McCrea RP et al (2009) Mapping metals in Parkinson's and normal brain using rapid-scanning x-ray fluorescence. Phys Med Biol 54(3):651–663PubMedCrossRef Gh Popescu BF, George MJ, Bergmann U, Garachtchenko AV, Kelly ME, McCrea RP et al (2009) Mapping metals in Parkinson's and normal brain using rapid-scanning x-ray fluorescence. Phys Med Biol 54(3):651–663PubMedCrossRef
18.
19.
Zurück zum Zitat McCrea RP, Harder SL, Martin M, Buist R, Nichol H (2008) A comparison of rapid-scanning X-ray fluorescence mapping and magnetic resonance imaging to localize brain iron distribution. Eur J Radiol 68S(3):S109–S113CrossRef McCrea RP, Harder SL, Martin M, Buist R, Nichol H (2008) A comparison of rapid-scanning X-ray fluorescence mapping and magnetic resonance imaging to localize brain iron distribution. Eur J Radiol 68S(3):S109–S113CrossRef
20.
Zurück zum Zitat Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, Cavalcanti F et al (1996) Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271(5254):1423–1427PubMedCrossRef Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, Cavalcanti F et al (1996) Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271(5254):1423–1427PubMedCrossRef
21.
Zurück zum Zitat Durr A, Cossee M, Agid Y, Campuzano V, Mignard C, Penet C et al (1996) Clinical and genetic abnormalities in patients with Friedreich's ataxia. N Engl J Med 335(16):1169–1175PubMedCrossRef Durr A, Cossee M, Agid Y, Campuzano V, Mignard C, Penet C et al (1996) Clinical and genetic abnormalities in patients with Friedreich's ataxia. N Engl J Med 335(16):1169–1175PubMedCrossRef
22.
Zurück zum Zitat Pandolfo M (1998) Molecular genetics and pathogenesis of Friedreich ataxia. Neuromuscul Disord 8(6):409–415PubMedCrossRef Pandolfo M (1998) Molecular genetics and pathogenesis of Friedreich ataxia. Neuromuscul Disord 8(6):409–415PubMedCrossRef
23.
Zurück zum Zitat Genis D, Matilla T, Volpini V, Rosell J, Davalos A, Ferrer I et al (1995) Clinical, neuropathologic, and genetic studies of a large spinocerebellar ataxia type 1 (SCA1) kindred: (CAG) n expansion and early premonitory signs and symptoms. Neurology 45(1):24–30PubMed Genis D, Matilla T, Volpini V, Rosell J, Davalos A, Ferrer I et al (1995) Clinical, neuropathologic, and genetic studies of a large spinocerebellar ataxia type 1 (SCA1) kindred: (CAG) n expansion and early premonitory signs and symptoms. Neurology 45(1):24–30PubMed
24.
Zurück zum Zitat Estrada R, Galarraga J, Orozco G, Nodarse A, Auburger G (1999) Spinocerebellar ataxia 2 (SCA2): morphometric analyses in 11 autopsies. Acta Neuropathol 97(3):306–310PubMedCrossRef Estrada R, Galarraga J, Orozco G, Nodarse A, Auburger G (1999) Spinocerebellar ataxia 2 (SCA2): morphometric analyses in 11 autopsies. Acta Neuropathol 97(3):306–310PubMedCrossRef
25.
Zurück zum Zitat Durr A, Smadja D, Cancel G, Lezin A, Stevanin G, Mikol J et al (1995) Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies). Clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families. Brain 118(Pt 6):1573–81PubMedCrossRef Durr A, Smadja D, Cancel G, Lezin A, Stevanin G, Mikol J et al (1995) Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies). Clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families. Brain 118(Pt 6):1573–81PubMedCrossRef
26.
Zurück zum Zitat Martin JJ, Van Regemorter N, Krols L, Brucher JM, de Barsy T, Szliwowski H et al (1994) On an autosomal dominant form of retinal-cerebellar degeneration: an autopsy study of five patients in one family. Acta Neuropathol 88(4):277–286PubMedCrossRef Martin JJ, Van Regemorter N, Krols L, Brucher JM, de Barsy T, Szliwowski H et al (1994) On an autosomal dominant form of retinal-cerebellar degeneration: an autopsy study of five patients in one family. Acta Neuropathol 88(4):277–286PubMedCrossRef
27.
Zurück zum Zitat Gouw LG, Digre KB, Harris CP, Haines JH, Ptacek LJ (1994) Autosomal dominant cerebellar ataxia with retinal degeneration: clinical, neuropathologic, and genetic analysis of a large kindred. Neurology 44(8):1441–1447PubMed Gouw LG, Digre KB, Harris CP, Haines JH, Ptacek LJ (1994) Autosomal dominant cerebellar ataxia with retinal degeneration: clinical, neuropathologic, and genetic analysis of a large kindred. Neurology 44(8):1441–1447PubMed
28.
Zurück zum Zitat Hammans SR, Kennedy CR (1998) Ataxia with isolated vitamin E deficiency presenting as mutation negative Friedreich's ataxia. J Neurol Neurosurg Psychiatry 64(3):368–370PubMedCrossRef Hammans SR, Kennedy CR (1998) Ataxia with isolated vitamin E deficiency presenting as mutation negative Friedreich's ataxia. J Neurol Neurosurg Psychiatry 64(3):368–370PubMedCrossRef
29.
Zurück zum Zitat Yokota T, Uchihara T, Kumagai J, Shiojiri T, Pang JJ, Arita M et al (2000) Postmortem study of ataxia with retinitis pigmentosa by mutation of the alpha-tocopherol transfer protein gene. J Neurol Neurosurg Psychiatry 68(4):521–525PubMedCrossRef Yokota T, Uchihara T, Kumagai J, Shiojiri T, Pang JJ, Arita M et al (2000) Postmortem study of ataxia with retinitis pigmentosa by mutation of the alpha-tocopherol transfer protein gene. J Neurol Neurosurg Psychiatry 68(4):521–525PubMedCrossRef
30.
Zurück zum Zitat Larnaout A, Belal S, Zouari M, Feki M, Ben Hamida C, Goebel HH et al (1997) Friedreich's ataxia with isolated vitamin E deficiency: a neuropathological study of a Tunisian patient. Acta Neuropathol 8:416–425 Larnaout A, Belal S, Zouari M, Feki M, Ben Hamida C, Goebel HH et al (1997) Friedreich's ataxia with isolated vitamin E deficiency: a neuropathological study of a Tunisian patient. Acta Neuropathol 8:416–425
31.
Zurück zum Zitat Orr HT, Klockgether T (2000) Spinocerebellar ataxia 1. In: Klockgether T (ed) Handbook of ataxia disorders. Marcel Dekker, Inc, New York, pp 343–361 Orr HT, Klockgether T (2000) Spinocerebellar ataxia 1. In: Klockgether T (ed) Handbook of ataxia disorders. Marcel Dekker, Inc, New York, pp 343–361
32.
Zurück zum Zitat Bürk K, Dichgans J (2000) Spinocerebellar ataxia type 2. In: Klockgether T (ed) Handbook of ataxia disorders. Marcel Dekker, Inc, New York, pp 363–384 Bürk K, Dichgans J (2000) Spinocerebellar ataxia type 2. In: Klockgether T (ed) Handbook of ataxia disorders. Marcel Dekker, Inc, New York, pp 363–384
33.
Zurück zum Zitat Stevanin G, Durr A, Brice A (2000) Spinocerebellar ataxia type 7. In: Klockgether T (ed) Handbook of ataxia disorders. Marcel Dekker, Inc, New York, pp 469–486 Stevanin G, Durr A, Brice A (2000) Spinocerebellar ataxia type 7. In: Klockgether T (ed) Handbook of ataxia disorders. Marcel Dekker, Inc, New York, pp 469–486
34.
Zurück zum Zitat Koenig M (2000) Ataxia with isolated vitamin E deficiency. In: Klockgether T (ed) Handbook of ataxia disorders. Marcel Dekker, Inc, New York, pp 223–234 Koenig M (2000) Ataxia with isolated vitamin E deficiency. In: Klockgether T (ed) Handbook of ataxia disorders. Marcel Dekker, Inc, New York, pp 223–234
35.
Zurück zum Zitat Dickson DW, Lin W, Liu WK, Yen SH (1999) Multiple system atrophy: a sporadic synucleinopathy. Brain Pathol 9(4):721–732PubMedCrossRef Dickson DW, Lin W, Liu WK, Yen SH (1999) Multiple system atrophy: a sporadic synucleinopathy. Brain Pathol 9(4):721–732PubMedCrossRef
36.
Zurück zum Zitat Papp MI, Kahn JE, Lantos PL (1989) Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 94(1–3):79–100PubMedCrossRef Papp MI, Kahn JE, Lantos PL (1989) Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 94(1–3):79–100PubMedCrossRef
37.
Zurück zum Zitat Cuajungco MP, Lees GJ (1997) Zinc metabolism in the brain: relevance to human neurodegenerative disorders. Neurobiol Dis 4(3–4):137–169PubMedCrossRef Cuajungco MP, Lees GJ (1997) Zinc metabolism in the brain: relevance to human neurodegenerative disorders. Neurobiol Dis 4(3–4):137–169PubMedCrossRef
38.
Zurück zum Zitat Madsen E, Gitlin JD (2007) Copper and iron disorders of the brain. Annu Rev Neurosci 30:317–337PubMedCrossRef Madsen E, Gitlin JD (2007) Copper and iron disorders of the brain. Annu Rev Neurosci 30:317–337PubMedCrossRef
40.
Zurück zum Zitat Ortiz E, Pasquini JM, Thompson K, Felt B, Butkus G, Beard J et al (2004) Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models. J Neurosci Res 77(5):681–689PubMedCrossRef Ortiz E, Pasquini JM, Thompson K, Felt B, Butkus G, Beard J et al (2004) Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models. J Neurosci Res 77(5):681–689PubMedCrossRef
41.
Zurück zum Zitat Todorich B, Pasquini JM, Garcia CI, Paez PM, Connor JR (2008) Oligodendrocytes and myelination: The role of iron. Glia 57(5):467–478CrossRef Todorich B, Pasquini JM, Garcia CI, Paez PM, Connor JR (2008) Oligodendrocytes and myelination: The role of iron. Glia 57(5):467–478CrossRef
42.
Zurück zum Zitat Tsang D, Tsang YS, Ho WK, Wong RN (1997) Myelin basic protein is a zinc-binding protein in brain: possible role in myelin compaction. Neurochem Res 22(7):811–819PubMedCrossRef Tsang D, Tsang YS, Ho WK, Wong RN (1997) Myelin basic protein is a zinc-binding protein in brain: possible role in myelin compaction. Neurochem Res 22(7):811–819PubMedCrossRef
43.
Zurück zum Zitat Kursula P, Merilainen G, Lehto VP, Heape AM (1999) The small myelin-associated glycoprotein is a zinc-binding protein. J Neurochem 73(5):2110–2118PubMed Kursula P, Merilainen G, Lehto VP, Heape AM (1999) The small myelin-associated glycoprotein is a zinc-binding protein. J Neurochem 73(5):2110–2118PubMed
44.
Zurück zum Zitat Ludwin SK, Johnson ES (1981) Evidence for a "dying-back" gliopathy in demyelinating disease. Ann Neurol 9(3):301–305PubMedCrossRef Ludwin SK, Johnson ES (1981) Evidence for a "dying-back" gliopathy in demyelinating disease. Ann Neurol 9(3):301–305PubMedCrossRef
45.
Zurück zum Zitat Rodriguez M, Scheithauer BW, Forbes G, Kelly PJ (1993) Oligodendrocyte injury is an early event in lesions of multiple sclerosis. Mayo Clin Proc 68(7):627–636PubMed Rodriguez M, Scheithauer BW, Forbes G, Kelly PJ (1993) Oligodendrocyte injury is an early event in lesions of multiple sclerosis. Mayo Clin Proc 68(7):627–636PubMed
46.
Zurück zum Zitat Connor JR, Menzies SL (1996) Relationship of iron to oligodendrocytes and myelination. Glia 17(2):83–93PubMedCrossRef Connor JR, Menzies SL (1996) Relationship of iron to oligodendrocytes and myelination. Glia 17(2):83–93PubMedCrossRef
47.
Zurück zum Zitat Morris CM, Candy JM, Oakley AE, Bloxham CA, Edwardson JA (1992) Histochemical distribution of non-haem iron in the human brain. Acta Anat (Basel) 144(3):235–257CrossRef Morris CM, Candy JM, Oakley AE, Bloxham CA, Edwardson JA (1992) Histochemical distribution of non-haem iron in the human brain. Acta Anat (Basel) 144(3):235–257CrossRef
48.
Zurück zum Zitat Hock A, Demmel U, Schicha H, Kasperek K, Feinendegen LE (1975) Trace element concentration in human brain. Activation analysis of cobalt, iron, rubidium, selenium, zinc, chromium, silver, cesium, antimony and scandium. Brain 98(1):49–64PubMedCrossRef Hock A, Demmel U, Schicha H, Kasperek K, Feinendegen LE (1975) Trace element concentration in human brain. Activation analysis of cobalt, iron, rubidium, selenium, zinc, chromium, silver, cesium, antimony and scandium. Brain 98(1):49–64PubMedCrossRef
49.
Zurück zum Zitat Brody H (1960) The deposition of aging pigment in the human cerebral cortex. J Gerontol 15:258–261PubMed Brody H (1960) The deposition of aging pigment in the human cerebral cortex. J Gerontol 15:258–261PubMed
51.
Zurück zum Zitat Bartzokis G, Tishler TA, Lu PH, Villablanca P, Altshuler LL, Carter M et al (2007) Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol Aging 28(3):414–423PubMedCrossRef Bartzokis G, Tishler TA, Lu PH, Villablanca P, Altshuler LL, Carter M et al (2007) Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol Aging 28(3):414–423PubMedCrossRef
52.
Zurück zum Zitat Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev, Neurosci 5(11):863–873CrossRef Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev, Neurosci 5(11):863–873CrossRef
53.
Zurück zum Zitat Ricchelli F, Fusi P, Tortora P, Valtorta M, Riva M, Tognon G et al (2007) Destabilization of non-pathological variants of ataxin-3 by metal ions results in aggregation/fibrillogenesis. Int J Biochem Cell Biol 39(5):966–977PubMedCrossRef Ricchelli F, Fusi P, Tortora P, Valtorta M, Riva M, Tognon G et al (2007) Destabilization of non-pathological variants of ataxin-3 by metal ions results in aggregation/fibrillogenesis. Int J Biochem Cell Biol 39(5):966–977PubMedCrossRef
54.
Zurück zum Zitat Miyajima H, Kono S, Takahashi Y, Sugimoto M, Sakamoto M, Sakai N (2001) Cerebellar ataxia associated with heteroallelic ceruloplasmin gene mutation. Neurology 57(12):2205–2210PubMed Miyajima H, Kono S, Takahashi Y, Sugimoto M, Sakamoto M, Sakai N (2001) Cerebellar ataxia associated with heteroallelic ceruloplasmin gene mutation. Neurology 57(12):2205–2210PubMed
55.
Zurück zum Zitat Bartzokis G (2004) Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging 25(1):5–18 author reply 49-62PubMedCrossRef Bartzokis G (2004) Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging 25(1):5–18 author reply 49-62PubMedCrossRef
56.
Zurück zum Zitat Bartzokis G, Lu PH, Tishler TA, Fong SM, Oluwadara B, Finn JP et al (2007) Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications. Neurochem Res 32(10):1655–1664PubMedCrossRef Bartzokis G, Lu PH, Tishler TA, Fong SM, Oluwadara B, Finn JP et al (2007) Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications. Neurochem Res 32(10):1655–1664PubMedCrossRef
57.
Zurück zum Zitat Graeber MB, Raivich G, Kreutzberg GW (1989) Increase of transferrin receptors and iron uptake in regenerating motor neurons. J Neurosci Res 23(3):342–345PubMedCrossRef Graeber MB, Raivich G, Kreutzberg GW (1989) Increase of transferrin receptors and iron uptake in regenerating motor neurons. J Neurosci Res 23(3):342–345PubMedCrossRef
58.
Zurück zum Zitat Raivich G, Graeber MB, Gehrmann J, Kreutzberg GW (1991) Transferrin receptor expression and iron uptake in the injured and regenerating rat sciatic nerve. Eur J NeuroSci 3(10):919–927PubMedCrossRef Raivich G, Graeber MB, Gehrmann J, Kreutzberg GW (1991) Transferrin receptor expression and iron uptake in the injured and regenerating rat sciatic nerve. Eur J NeuroSci 3(10):919–927PubMedCrossRef
59.
Zurück zum Zitat Penkowa M, Hidalgo J (2003) Treatment with metallothionein prevents demyelination and axonal damage and increases oligodendrocyte precursors and tissue repair during experimental autoimmune encephalomyelitis. J Neurosci Res 72(5):574–586PubMedCrossRef Penkowa M, Hidalgo J (2003) Treatment with metallothionein prevents demyelination and axonal damage and increases oligodendrocyte precursors and tissue repair during experimental autoimmune encephalomyelitis. J Neurosci Res 72(5):574–586PubMedCrossRef
60.
Zurück zum Zitat Penkowa M, Espejo C, Martinez-Caceres EM, Montalban X, Hidalgo J (2003) Increased demyelination and axonal damage in metallothionein I+II-deficient mice during experimental autoimmune encephalomyelitis. Cell Mol Life Sci 60(1):185–197PubMedCrossRef Penkowa M, Espejo C, Martinez-Caceres EM, Montalban X, Hidalgo J (2003) Increased demyelination and axonal damage in metallothionein I+II-deficient mice during experimental autoimmune encephalomyelitis. Cell Mol Life Sci 60(1):185–197PubMedCrossRef
61.
Zurück zum Zitat Maier CM, Chan PH (2002) Role of superoxide dismutases in oxidative damage and neurodegenerative disorders. Neuroscientist 8(4):323–334PubMedCrossRef Maier CM, Chan PH (2002) Role of superoxide dismutases in oxidative damage and neurodegenerative disorders. Neuroscientist 8(4):323–334PubMedCrossRef
62.
Zurück zum Zitat Bowling AC, Schulz JB, Brown RH Jr, Beal MF (1993) Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 61(6):2322–2325PubMedCrossRef Bowling AC, Schulz JB, Brown RH Jr, Beal MF (1993) Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 61(6):2322–2325PubMedCrossRef
63.
Zurück zum Zitat Brun A, Englund E (1986) A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 19(3):253–262PubMedCrossRef Brun A, Englund E (1986) A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 19(3):253–262PubMedCrossRef
64.
Zurück zum Zitat Faucheux BA, Bonnet AM, Agid Y, Hirsch EC (1999) Blood vessels change in the mesencephalon of patients with Parkinson's disease. Lancet 353(9157):981–982PubMedCrossRef Faucheux BA, Bonnet AM, Agid Y, Hirsch EC (1999) Blood vessels change in the mesencephalon of patients with Parkinson's disease. Lancet 353(9157):981–982PubMedCrossRef
65.
Zurück zum Zitat Boddaert N, Le Quan Sang KH, Rotig A, Leroy-Willig A, Gallet S, Brunelle F et al (2007) Selective iron chelation in Friedreich ataxia: biologic and clinical implications. Blood 110(1):401–408PubMedCrossRef Boddaert N, Le Quan Sang KH, Rotig A, Leroy-Willig A, Gallet S, Brunelle F et al (2007) Selective iron chelation in Friedreich ataxia: biologic and clinical implications. Blood 110(1):401–408PubMedCrossRef
66.
Zurück zum Zitat Waldvogel D, van Gelderen P, Hallett M (1999) Increased iron in the dentate nucleus of patients with Friedrich's ataxia. Ann Neurol 46(1):123–125PubMedCrossRef Waldvogel D, van Gelderen P, Hallett M (1999) Increased iron in the dentate nucleus of patients with Friedrich's ataxia. Ann Neurol 46(1):123–125PubMedCrossRef
67.
Zurück zum Zitat Koeppen AH, Michael SC, Knutson MD, Haile DJ, Qian J, Levi S et al (2007) The dentate nucleus in Friedreich's ataxia: the role of iron-responsive proteins. Acta Neuropathol (Berl) 114(2):163–173CrossRef Koeppen AH, Michael SC, Knutson MD, Haile DJ, Qian J, Levi S et al (2007) The dentate nucleus in Friedreich's ataxia: the role of iron-responsive proteins. Acta Neuropathol (Berl) 114(2):163–173CrossRef
Metadaten
Titel
Synchrotron X-ray Fluorescence Reveals Abnormal Metal Distributions in Brain and Spinal Cord in Spinocerebellar Ataxia: A Case Report
verfasst von
Bogdan F. Gh. Popescu
Christopher A. Robinson
L. Dean Chapman
Helen Nichol
Publikationsdatum
01.09.2009
Verlag
Springer-Verlag
Erschienen in
The Cerebellum / Ausgabe 3/2009
Print ISSN: 1473-4222
Elektronische ISSN: 1473-4230
DOI
https://doi.org/10.1007/s12311-009-0102-z

Weitere Artikel der Ausgabe 3/2009

The Cerebellum 3/2009 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.